These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Production and characterisation of monoclonal antibodies to outer-membrane-protein antigens of Vibrio cholerae O1. Kabir S J Med Microbiol; 1991 Mar; 34(3):167-73. PubMed ID: 1901361 [TBL] [Abstract][Full Text] [Related]
23. An immunochemical study of serological cross-reaction between lipopolysaccharides from Vibrio cholerae O22 and O139. Isshiki Y; Kondo S; Iguchi T; Sano Y; Shimada T; Hisatsune K Microbiology (Reading); 1996 Jun; 142 ( Pt 6)():1499-1504. PubMed ID: 8704989 [TBL] [Abstract][Full Text] [Related]
24. Immunological properties of Vibrio cholerae lipopolysaccharides. Nakano M; Tanabe MJ; Hori H; Kondo S; Hisatsune K Microbiol Immunol; 1977 Nov; 21(11):611-9. PubMed ID: 342874 [TBL] [Abstract][Full Text] [Related]
25. Role of cell surface antigens of Vibrio cholerae 01 and non 01 serovars in intestinal adhesion. Vijayashree S; Nayak N; Panigrahi D; Sehgal S Indian J Pathol Microbiol; 2003 Apr; 46(2):259-60. PubMed ID: 15022934 [TBL] [Abstract][Full Text] [Related]
26. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity. Svennerholm AM Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500 [TBL] [Abstract][Full Text] [Related]
27. Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development. Manning PA; Heuzenroeder MW; Yeadon J; Leavesley DI; Reeves PR; Rowley D Infect Immun; 1986 Aug; 53(2):272-7. PubMed ID: 2426198 [TBL] [Abstract][Full Text] [Related]
28. Antigenic analysis of Vibrio cholerate O1 by crossed immunoelectrophoresis. Kabir S Zentralbl Bakteriol Mikrobiol Hyg A; 1989 Jan; 270(3):361-72. PubMed ID: 2929189 [TBL] [Abstract][Full Text] [Related]
29. Unusual cross-reactions among monoclonal antibodies to bacterial antigens: idiotypic and competitive binding analysis. Ghosh S; Campbell AM FEMS Microbiol Immunol; 1988 Jan; 1(1):3-8. PubMed ID: 3272825 [TBL] [Abstract][Full Text] [Related]
30. Antibodies (IgG) to lipopolysaccharide of Vibrio cholerae O1 mediate protection through inhibition of intestinal adherence and colonisation in a mouse model. Mukhopadhyay S; Nandi B; Ghose AC FEMS Microbiol Lett; 2000 Apr; 185(1):29-35. PubMed ID: 10731603 [TBL] [Abstract][Full Text] [Related]
31. Enzyme-linked immunoassays for antibodies against Vibrio cholerae. Cooper GN; McNab CE; Jackson GD; Walker P Aust J Exp Biol Med Sci; 1983 Dec; 61 ( Pt 6)():713-25. PubMed ID: 6426450 [TBL] [Abstract][Full Text] [Related]
32. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes. Levinson KJ; Baranova DE; Mantis NJ Vaccine; 2016 Nov; 34(48):5833-5836. PubMed ID: 27773473 [TBL] [Abstract][Full Text] [Related]
33. Expression of Shigella sonnei lipopolysaccharide in Vibrio cholerae. Viret JF; Cryz SJ; Favre D Mol Microbiol; 1996 Mar; 19(5):949-63. PubMed ID: 8830276 [TBL] [Abstract][Full Text] [Related]
34. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine. Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896 [TBL] [Abstract][Full Text] [Related]
35. Determinants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits. Pierce NF; Cray WC; Kaper JB; Mekalanos JJ Infect Immun; 1988 Jan; 56(1):142-8. PubMed ID: 2447017 [TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes. Ebrahimizadeh W; Mousavi Gargari S; Rajabibazl M; Safaee Ardekani L; Zare H; Bakherad H Appl Microbiol Biotechnol; 2013 May; 97(10):4457-66. PubMed ID: 23135228 [TBL] [Abstract][Full Text] [Related]
37. Variable gene family usage of protective and non-protective anti-Vibrio cholerae O1 LPS antibody heavy chains. Wade TK; Wade WF Microbiol Immunol; 2008 Dec; 52(12):611-20. PubMed ID: 19120975 [TBL] [Abstract][Full Text] [Related]
38. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology. Levinson KJ; De Jesus M; Mantis NJ Infect Immun; 2015 Apr; 83(4):1674-83. PubMed ID: 25667263 [TBL] [Abstract][Full Text] [Related]
40. Immunochemical properties of the lipopolysaccharide O-antigen of Vibrio cholerae O1 in relation to its chemical structure. Guhathakurta B; Majumdar M; Sen AK; Sasmal D; Mukherjee AK; Datta A J Gen Microbiol; 1986 Jun; 132(6):1641-6. PubMed ID: 2433386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]